Acal (LON:ACL) Rating Reiterated by Peel Hunt

Acal (LON:ACL)‘s stock had its “buy” rating reissued by stock analysts at Peel Hunt in a research report issued to clients and investors on Tuesday, November 28th. They presently have a GBX 360 ($4.85) price objective on the stock. Peel Hunt’s price objective would suggest a potential downside of 0.55% from the company’s current price.

Several other analysts also recently commented on ACL. FinnCap reiterated a “buy” rating and issued a GBX 339 ($4.56) price target on shares of Acal in a research report on Tuesday, September 26th. Numis Securities reiterated a “buy” rating and issued a GBX 370 ($4.98) price target on shares of Acal in a research report on Monday, October 16th.

Acal (LON ACL) opened at GBX 362 ($4.87) on Tuesday. Acal has a twelve month low of GBX 210 ($2.83) and a twelve month high of GBX 365 ($4.91).

ILLEGAL ACTIVITY NOTICE: This piece was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The original version of this piece can be viewed at https://ledgergazette.com/2017/12/10/acal-acl-earns-buy-rating-from-peel-hunt.html.

About Acal

ACAL plc designs, manufactures and distributes electronic products and solutions. The Company operates through two segments: Custom Distribution and Design & Manufacturing. The Custom Distribution segment provides customized electronic, photonic and medical products to the industrial, medical and healthcare markets, both from a range of international suppliers and from the Company’s Design & Manufacturing division.

Receive News & Ratings for Acal plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acal plc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply